Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiovascular Risk Factors
Adipose tissue response to sex steroids aids understanding in reducing CV risk
January 12th, 2006
Adipose tissue response to sex steroids aids researchers understanding of hormone therapy in reducing cardiovascular risk. Researchers in Denmark conducted a study "to investigate how variation in the dose of the progestogen influence the impact of 17beta-estradiol plus drospirenone (DRSP) treatment on adipose tissue and its secretor function with direct implications for atherogenic metabolites." The design was a "randomized, double-blind, placebo-controlled trial [in a] primary care, single-study site." According to L.B. Tanko and C. Christiansen, "[The study population consisted of] a total of 240 healthy postmenopausal women 53-65 years old, 178...
Source: Women's Health Weekly (2006-01-12)
|
